Recombinant Cynomolgus/Rhesus macaque CD19 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00689P-100UG

Cynomolgus/Rhesus macaque CD19 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Cynomolgus/Rhesus macaque CD19 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-00689P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Cynomolgus/Rhesus macaque CD19 Protein is expressed from HEK293 with His tag at the N-Terminus.; It contains Gln21 - Trp291. |
Purity | > 95% as determined by Tris-Bis PAGE |
Accession | A0A2K5W8L9 |
Target Symbol | CD19 |
Species | Cynomolgus/Rhesus macaque |
Expression System | HEK293 |
Tag | N-His |
Expression Range | Gln21 - Trp291 |
Mol. Weight | The protein has a predicted MW of 30.96 kDa. Due to glycosylation, the protein migrates to 50 - 70 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1 EU per ug by the LAL method. |
Activity | The affinity constant of 0.48 uM as determined in SPR assay (Biacore T200). Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | CD19 is a 95 kDa transmembrane glycoprotein that plays a central role in B cell activation and humoral immune responses.Functions as coreceptor for the B-cell antigen receptor complex (BCR) on B-lymphocytes. Decreases the threshold for activation of downstream signaling pathways and for triggering B-cell responses to antigens. Activates signaling pathways that lead to the activation of phosphatidylinositol 3-kinase and the mobilization of intracellular Ca2 stores. |